189 related articles for article (PubMed ID: 28886809)
1. Detection of Genetic Aberrations in the Assessment and Prognosis of Melanoma.
High WA
Dermatol Clin; 2017 Oct; 35(4):525-536. PubMed ID: 28886809
[TBL] [Abstract][Full Text] [Related]
2. Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing.
Lang UE; Yeh I; McCalmont TH
Clin Lab Med; 2017 Sep; 37(3):473-484. PubMed ID: 28802496
[TBL] [Abstract][Full Text] [Related]
3. The impact of molecular morphology techniques on the expert diagnosis in melanocytic skin neoplasms.
Ferrara G; Misciali C; Brenn T; Cerroni L; Kazakov DW; Perasole A; Russo R; Ricci R; Crisman G; Fanti PA; Passarini B; Patrizi A
Int J Surg Pathol; 2013 Oct; 21(5):483-92. PubMed ID: 23775023
[TBL] [Abstract][Full Text] [Related]
4. Molecular diagnostics for ambiguous melanocytic tumors.
Shahbain H; Cooper C; Gerami P
Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral heterogeneity of chromosome 9 loss and CDKN2A (p16) protein expression in a morphologically challenging spitzoid melanoma.
DiSano K; Tschen JA; Cho-Vega JH
Am J Dermatopathol; 2013 Apr; 35(2):277-80. PubMed ID: 23221484
[TBL] [Abstract][Full Text] [Related]
6. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry.
Nagarajan P; Tetzlaff MT; Curry JL; Prieto VG
Actas Dermosifiliogr; 2017; 108(1):17-30. PubMed ID: 27344067
[TBL] [Abstract][Full Text] [Related]
7. [Molecular diagnosis of melanocytic tumors].
Bauer J
Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
[TBL] [Abstract][Full Text] [Related]
8. Difficult to Diagnose Cutaneous Melanoma in a Patient with BAP1 Tumor Predisposition Syndrome.
Silva-Clavería F; Álvarez-Muñoz A; Ferrándiz L; Fernández-Orland A; Conde-Martin AF; Moreno-Ramírez D; Ríos-Martín JJ
Int J Surg Pathol; 2023 Oct; 31(7):1398-1402. PubMed ID: 36803128
[TBL] [Abstract][Full Text] [Related]
9. Molecular Profiling in Cutaneous Melanoma.
Ji AL; Bichakjian CK; Swetter SM
J Natl Compr Canc Netw; 2016 Apr; 14(4):475-80. PubMed ID: 27059194
[TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
[TBL] [Abstract][Full Text] [Related]
11. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of epithelial and melanocitic markers with double sequential immunohistochemical staining in differentiating melanoma in situ from invasive melanoma.
Parra-Medina R; Morales SD
Ann Diagn Pathol; 2017 Feb; 26():70-74. PubMed ID: 27594302
[TBL] [Abstract][Full Text] [Related]
13. What's new in prognostication of melanoma in the dermatopathology laboratory?
Bangash HK; Romegialli A; Dadras SS
Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451
[TBL] [Abstract][Full Text] [Related]
14. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.
March J; Hand M; Truong A; Grossman D
J Am Acad Dermatol; 2015 Jun; 72(6):943-58; quiz 959-60. PubMed ID: 25980999
[TBL] [Abstract][Full Text] [Related]
15. [Fluorescence in-situ hybridization as a diagnostic tool for cutaneous melanoma].
Su J; Liu J; Zheng J; You J; Ma X; Zhang Y; Zhang J; Liao S
Zhonghua Bing Li Xue Za Zhi; 2015 Jan; 44(1):37-41. PubMed ID: 25765029
[TBL] [Abstract][Full Text] [Related]
16. Prognostic tissue markers in melanoma.
Moore DA; Pringle JH; Saldanha GS
Histopathology; 2012 Apr; 60(5):679-89. PubMed ID: 21880059
[TBL] [Abstract][Full Text] [Related]
17. Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children.
Tom WL; Hsu JW; Eichenfield LF; Friedlander SF
J Am Acad Dermatol; 2011 Mar; 64(3):559-72. PubMed ID: 21255872
[TBL] [Abstract][Full Text] [Related]
18. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
de la Fouchardière A; Vergier B
Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
[No Abstract] [Full Text] [Related]
19. Molecular techniques for predicting behaviour in melanocytic neoplasms.
Lee CY; Gerami P
Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
[TBL] [Abstract][Full Text] [Related]
20. Molecular markers in melanoma.
Kashani-Sabet M
Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]